Journals / Yeni Tıp Dergisi / 2011 / Cilt: 28 - Sayı: 2

Eklem tutulumu olan veya olmayan Behçet hastalarında anti-CCP antikorları

Anti-CCP Antibodies in Behcet's Disease with or without articular Involvement

Pages
92–94
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies are needed, but we believe that these autoantibodies can be used in differential diagnosis of RA and BD arthritis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Articular involvement is an important component of Behcet’s disease, which occasionally can be the only initial manifestation that makes the differential diagnosis difficult.
📊
Key Findings & Data:Methods: Anti-CCP antibodies were measured in 30 patients with BD, 16 patients with RA, and 14 with OA.
💡
Conclusion & Impact:Further studies are needed, but we believe that these autoantibodies can be used in differential diagnosis of RA and BD arthritis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Peptidler · siklik · Antikorlar

Abstract

Objective: Articular involvement is an important component of Behcet’s disease, which occasionally can be the only initial manifestation that makes the differential diagnosis difficult. Autoantibodies to cyclic citrullinated peptide are particularly remarkable because of their high specificity for RA. The objective of the study was to determine the association of anti-CCP in BD with or without articular involvement, and to compare the results with rheumatoid arthritis and osteoarthritis (OA). Methods: Anti-CCP antibodies were measured in 30 patients with BD, 16 patients with RA, and 14 with OA. Sixteen of 30 BD patients had experienced arthritis, the remainder had no articular involvement. Results: Only one (3.3%) patient diagnosed with BD, who also suffered from arthritis, had anti-CCP positivity. Eleven (69%) patients with RA and one (7%) with OA had anti-CCP antibodies above the cut-off level. There was no statistically significant correlation between anti- CCP antibodies and BD (P>0.05), and OA (P>0.05), however, RA can be distinguished significantly from BD and osteoarthritis (P<0.01). Conclusions: Anti-CCP antibodies have no diagnostic value in BD and its articular involvement, and the results are not different from OA which is a noninflammatory articular disease. Further studies are needed, but we believe that these autoantibodies can be used in differential diagnosis of RA and BD arthritis.

Özet

Amaç: Eklem tutulumu Behçet hastalığının (BH) önemli bir bileşenidir ve bazen ayırıcı tanıyı zor hale getiren tek başlangıç bulgusu olabilir. Siklik sitrüline peptid (CCP)’e karşı otoantikorlar RA için yüksek özgüllükleri nedeniyle özellikle dikkati çekmektedirler. Çalışmanın amacı eklem tutulumu olan veya olmayan BH ile anti-CCP ilişkisini belirlemek ve sonuçları romatoid artrit (RA) ve osteoartrit (OA) ile karşılaştırmaktır. Materyal ve Metot: Anti-CCP antikorları BH olan 30 hastada, RA olan 16 hastada ve OA olan 14 hastada ölçüldü. 30 BH hastasının onaltısında artrit vardı, geri kalanlarda hiçbir eklem tutulumu yoktu. Bulgular: BD tanısı ve aynı zamanda artriti olan sadece bir hastada (%3.3), anti-CCP pozitifliği vardı. RA olan hastaların onbiri (69%) ve OA olanların birinde (%7) anti-CCP antikor düzeyi katof değerin üstünde idi. Anti- CCP antikor düzeyi ile BH (P>0,05) ve OA (P>0,05) arasında istatistiksel olarak anlamlı ilişki yoktu ancak RA, BH ve osteoartritten anlamlı şekilde ayırt edilebilir (p< 0.01). Sonuç: Anti-CCP antikorlarının BH ve eklem tutulumunda tanısal değeri yoktur ve sonuçlar noninflamatuar bir eklem hastalığı olan OA’den farklı değildir. Ileri çalışmalara ihtiyaç vardır, ancak biz bu otoantikorların RA ve BH artriti ayırıcı tanısında kullanılabileceğini düşünmekteyiz.

🔖

Cite This Article

KÖSEOĞLU, H. K., YÜCETÜRK, T. E., BAYRAKTAR, N., TUFAN, M. A., GENCER, M., YÜCEL, A. E. (2011). Eklem tutulumu olan veya olmayan Behçet hastalarında anti-CCP antikorları. Yeni Tıp Dergisi, Cilt: 28 - Sayı: 2, 92–94. https://ajindex.com/articles/338266

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Yazici H, Yurdakul S, Hamuryudan V, Fresko I. Behçet’s Syndrome. Edited By: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. Rheumatology (Third Edition), Edinburgh, Mosby 2003; 1665-69
  2. Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease. Int J Dermatol 2003;42(5):346-51
  3. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet 1990;335(18697):1078-80
  4. Yurdakul S, Yazici H, Tuzun Y, Pazarli H, Yalcin B, Altac M, et al. The arthritis of Behcet’s disease: a prospective study. Ann Rheum Dis 1983;42(5):505-15
  5. Kim HA, Choi KW, Song YW. Arthropathy in Behcet’s disease. Scand J Rheumatol 1997;26(2):125-9
  6. Gur A, Sarac AJ, Burkan YK, Nas K, Cevik R. Arthropathy, quality of life, depression, and anxiety in Behcet’s disease: relationship between arthritis and these factors. Clin Rheumatol 2006;25(4):524-31
  7. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31(3):315-24. 8. van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 2002;4(2):87-93
  8. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007;146(11):797-808
  9. Fathi NA, Ezz-Eldin AM, Mosad E, Bakry RM, Hamed HB, Ahmed S, et al. Diagnostic performance and predictive value of rheumatoid factor, anti-cyclic-citrullinated peptide antibodies and HLA-DRB1 locus genes in rheumatoid arthritis. Int Arch Med 2008;1(1):20
  10. Dubrous P, Gardet V, Hugard I. Value of anti-cyclic citrullinated peptides antibodies in comparison with rheumatoid factor for rheumatoid arthritis diagnosis. Pathol Biol (Paris) 2005;53(2):63-7
  11. Bas S, Perneger TV, Seitz M, Tiercy JM, Roux-Lombard P, Guerne PA. Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies, and IgM rheumatoid factors. Rheumatology (Oxford) 2002;41(7):809-14
  12. Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA. Rheumatoid factor and antibodies to cyclic citrullinated